Blood Pressure Monitoring Devices Archives - DelveInsight
PDF) Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations | Nature Communications
FDA Grants Breakthrough Device Designation for Roche Alzheimer's Early-Detection Solution | Clinical Lab Products
Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation | Alzheimer's Research & Therapy | Full Text
PDF) Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging
Roche announces collaboration with Lilly to enhance early diagnosis of Alzheimer's disease
Панель Elecsys Amyloid Plasma Panel компании Roche получила статус прорывного устройства FDA для своевременной диагностики болезни Альцгеймера - ТехМедЭКСПО
Roche's Elecsys Amyloid Plasma Panel Granted FDA Breakthrough Device Designation to Enable a Timely Diagnosis of Alzheimer's Disease
Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques | Neurology
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS - ScienceDirect
Roche Alzheimer's disease Cerebrospinal Fluid (CSF) assays receive FDA clearance, supporting more accurate and timely diagnosis
Impact of pre‐analytical sample handling factors on plasma biomarkers of Alzheimer's disease - Kurz - Journal of Neurochemistry - Wiley Online Library
Roche, Lilly partner to boost early diagnosis of Alzheimer's disease
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS - ScienceDirect
The Power of Elecsys® in Alzheimer's disease
Tau PET correlates with different Alzheimer's disease‐related features compared to CSF and plasma p‐tau biomarkers | EMBO Molecular Medicine
Roche, Lilly partner on early diagnosis of Alzheimer's disease | LabPulse.com
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays | Scientific Reports
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease | Nature Medicine
Roche colabora con Lilly en la mejora del diagnóstico precoz de la enfermedad de Alzheimer | NGD - Noticias y Gestión de la Dependencia
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
